Cantargia's European Patent for Solid Tumours Remains in Force

STOCKHOLM, Jan. 19, 2017 /PRNewswire/ -- The opposition proceedings at the European Patent Office ("EPO") concerning Cantargia AB's ("Cantargia") patent for treatment of solid tumours have now been completed. The EPO has rejected the opposition and Cantargia's patent is thus...

from PR Newswire: //http://ift.tt/2royGCm